RESUMEN
BACKGROUND: Cannabis can alleviate pain of various etiologies. This study assessed the effect of cannabis on motor symptoms and pain parameters in patients with Parkinson's disease (PD). METHODS: Twenty patients with PD who were licensed to use cannabis underwent evaluation before and 30 min after cannabis consumption and again after long-term use. Motor function was assessed with the Unified PD Rating scale (UPDRS) by two raters, one blinded. Pain was assessed with the Pain Rating Index (PRI) and Visual Analogue Scale (VAS) of the short-form McGill Pain Questionnaire. Thermal quantitative sensory testing (QST) was performed in 18 patients. The two consecutive QST measurements were validated in 12 cannabis-naïve patients with PD. RESULTS: There was a significant decrease from baseline to 30 min after cannabis consumption in mean motor UPDRS score (38.1 ± 18 to 30.4 ± 15.6, p < 0.0001), total PRI (27 ± 13.5 to 9.7 ± 11, p = 0.001), and VAS score (6.4 ± 2.8 to 3.6 ± 3.1, p = 0.0005). Mean cold pain threshold decreased significantly in the more affected limb, but only after exclusion of two patients who consumed cannabis by vaporizer rather than smoking (19.5 ± 5.2 to 15.6 ± 8.7 °C, p = 0.02). After long-term (median 14 weeks) exposure, mean heat pain threshold decreased significantly in the more affected limb in all treated patients (43.6 ± 3.5 to 40.9 ± 3.3 °C, p = 0.05) and in cannabis smokers (43.7 ± 3.6 to 40.3 ± 2.5 °C, p = 0.008). CONCLUSIONS: Cannabis improved motor scores and pain symptoms in PD patients, together with a dissociate effect on heat and cold pain thresholds. Peripheral and central pathways are probably modulated by cannabis. SIGNIFICANCE: Quantitative sensory test results are significantly altered following cannabis consumption in patients with PD. Cannabis probably acts on pain in PD via peripheral and central pathways.
Asunto(s)
Marihuana Medicinal/uso terapéutico , Dolor/tratamiento farmacológico , Dolor/etiología , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/tratamiento farmacológico , Sensación Térmica/efectos de los fármacos , Administración por Inhalación , Adulto , Anciano , Frío , Femenino , Calor , Humanos , Masculino , Fumar Marihuana/psicología , Marihuana Medicinal/administración & dosificación , Persona de Mediana Edad , Trastornos del Movimiento/tratamiento farmacológico , Trastornos del Movimiento/fisiopatología , Dimensión del Dolor , Umbral Sensorial/efectos de los fármacosRESUMEN
Congenital Toxoplasma gondii infection can result in intracranial calcification, hydrocephalus and retinochoroiditis. Acquired infection is commonly associated with ocular disease. Pathology is characterized by strong proinflammatory responses. Ligation of ATP by purinergic receptor P2X(7), encoded by P2RX7, stimulates proinflammatory cytokines and can lead directly to killing of intracellular pathogens. To determine whether P2X(7) has a role in susceptibility to congenital toxoplasmosis, we examined polymorphisms at P2RX7 in 149 child/parent trios from North America. We found association (FBAT Z-scores +/-2.429; P=0.015) between the derived C(+)G(-) allele (f=0.68; OR=2.06; 95% CI: 1.14-3.75) at single-nucleotide polymorphism (SNP) rs1718119 (1068T>C; Thr-348-Ala), and a second synonymous variant rs1621388 in linkage disequilibrium with it, and clinical signs of disease per se. Analysis of clinical subgroups showed no association with hydrocephalus, with effect sizes for associations with retinal disease and brain calcifications enhanced (OR=3.0-4.25; 0.004
Asunto(s)
Coriorretinitis/genética , Predisposición Genética a la Enfermedad/genética , Receptores Purinérgicos P2/genética , Toxoplasmosis Congénita/genética , Adulto , Brasil , Preescolar , Coriorretinitis/etiología , Femenino , Estudio de Asociación del Genoma Completo , Haplotipos/genética , Humanos , Patrón de Herencia/genética , Desequilibrio de Ligamiento , Modelos Logísticos , Masculino , América del Norte , Polimorfismo de Nucleótido Simple/genética , Receptores Purinérgicos P2X7 , Toxoplasmosis Congénita/complicacionesRESUMEN
BACKGROUND: Velocardiofacial syndrome (VCFS) is a microdeletion syndrome caused by a 22q11.2 chromosomal deletion. METHODS: In this study, parents reported on their own temperament as well as the temperament of their child. Sixty-seven children with VCFS (mean age = 10.8, SD = 2.8; range 6-15), and age-, race- and gender-ratio matched samples of 47 community control participants (mean age = 10.4, SD = 2.6; range 6-15), and 18 sibling control participants (mean age = 12.1, SD = 1.9; range 9-15) took part in the current project. RESULTS: Children with VCFS have a temperament that may best be described as modestly difficult; while participants with VCFS were not more difficult across all temperamental domains, children with VCFS were rated by their parents as being: (1) less regular in their daily habits (e.g. eating at the same time each day, etc.); (2) less able to focus/sustain attention; (3) less cheerful/pleasant; (4) less likely to stay with an activity for a long time; and (5) less able to respond flexibly to changes in the environment. CONCLUSIONS: The best predictors of parent report of behavioural symptoms in children with VCFS were poor concordance between parent and child temperament across general activity level and mood domains.
Asunto(s)
Síndrome de DiGeorge/epidemiología , Síndrome de DiGeorge/psicología , Trastornos Mentales/epidemiología , Temperamento , Adolescente , Niño , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/epidemiología , Femenino , Humanos , Masculino , Trastornos Mentales/diagnóstico , Trastornos Mentales/psicología , Medio Social , Encuestas y Cuestionarios , Escalas de WechslerRESUMEN
OBJECTIVE: To find out whether there is an association between cultures positive for coagulase negative staphylococci (CONS) taken from babies in the Neonatal Intensive Care Unit (NICU) and a subsequent outcome of cerebral palsy. STUDY DESIGN: At delivery, we obtained cultures from the chorioamnion space and, when medically indicated, we obtained bacterial cultures from children in the NICU. Surviving neonates underwent final examination for cerebral palsy at age 18 months. RESULTS: Of six children in the Magnesium and Neurologic Endpoints Trial who had cerebral palsy, chorioamnion cultures had been obtained for five of six. Four of these five children (80%) had CONS-positive cultures, whereas 26 of 102 (25%) children without cerebral palsy were CONS positive (p = 0.02). In the NICU, of children with cerebral palsy, the prevalence of culture-proven CONS was 80% (4/5); for those without cerebral palsy, the prevalence was 17% (15/86) (p = 0.01). Using multivariable logistic regression to control for confounding, CONS in the chorioamnion remained significant (adjusted odds ratio [OR] 37.7, 95% confidence interval [CI] 3.0 to +infinity; p = 0.003). However, when controlled for extremely low birth weight, nonvertex presentation, and being on a ventilator > or = 20 days, the association between culture-proven CONS in the NICU and cerebral palsy became insignificant (adjusted OR 3.0, 95% CI 0.2 to +infinity; p = 0.42). CONCLUSION: CONS in the chorioamnion space are associated with cerebral palsy, but in these data, CONS in the NICU are not found to be associated with cerebral palsy.
Asunto(s)
Amnios/microbiología , Parálisis Cerebral/microbiología , Corion/microbiología , Adulto , Femenino , Humanos , Lactante , Recién Nacido , Modelos Logísticos , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
This review discusses the research published in the last five years on the behavioral, genetic, medical, and neuroscience aspects of Down syndrome. The subject areas that have experienced the most active research include Alzheimer disease, language development, leukemia, and pregnancy screening and diagnosis. These and other areas are reviewed.
Asunto(s)
Síndrome de Down/diagnóstico , Síndrome de Down/genética , Síndrome de Down/rehabilitación , Intervención Educativa Precoz , Femenino , Pruebas Genéticas , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Diagnóstico Prenatal , Resultado del TratamientoAsunto(s)
Toxoplasmosis Congénita/tratamiento farmacológico , Niño , Diagnóstico Diferencial , Oftalmopatías/tratamiento farmacológico , Femenino , Humanos , Recién Nacido , Transmisión Vertical de Enfermedad Infecciosa , Embarazo , Complicaciones Parasitarias del Embarazo , Diagnóstico Prenatal , Pirimetamina/uso terapéutico , Recurrencia , Factores de Riesgo , Sulfadiazina/uso terapéutico , Toxoplasmosis Congénita/complicaciones , Toxoplasmosis Congénita/diagnóstico , Toxoplasmosis Congénita/transmisiónRESUMEN
Coagulase-negative staphylococci were cultured from the space between the placental membranes at delivery in four of five neonates who were later diagnosed with cerebral palsy, and in 26 of 102 neonates who were not found to have the disorder (p=0.02).
Asunto(s)
Parálisis Cerebral/epidemiología , Parálisis Cerebral/microbiología , Recien Nacido Prematuro , Complicaciones Infecciosas del Embarazo/microbiología , Infecciones Estafilocócicas/complicaciones , Coagulasa/metabolismo , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , EmbarazoRESUMEN
We report the first case of maternal uniparental disomy for chromosome 6 (UPD6mat) ascertained through congenital adrenal hyperplasia (CAH), which arose because of reduction to homozygosity of an autosomal recessive mutation. This case suggests that UPD6mat is associated with intrauterine growth retardation (IUGR). A case of paternal UPD (involving only the short arm of chromosome 6) ascertained as CAH has previously been reported, but was not stated to have IUGR. Our patient was born with IUGR followed by extraordinarily good catch-up growth. She had a history of a marked lag in motor development. She presented at 2.65 y of age with pubarche of 3 mo duration, clitoral enlargement, and an advanced bone age. Simple virilizing CAH was diagnosed by elevations of plasma 17-hydroxyprogesterone and testosterone. Mutation analysis showed that the CAH was due to homozygosity for the 1172N exon 4 mutation. When parental DNA was examined, the mother was found to be heterozygous for the uncommon exon 4 mutation, while the father had no detectable mutations. DNA microsatellite analysis was subsequently performed on the patient and parents using polymorphic markers spanning the entire chromosome 6. Seven markers were informative for inheritance of a single maternal allele and absence of paternal alleles in the proband. Analysis of microsatellite markers from other chromosomes confirmed biparental inheritance at these loci. This combination of findings is diagnostic of UPD6mat. The only other reported case of UPD6mat was discovered serendipitously when genotyped for renal transplantation; this patient had a history of IUGR. Since both cases of UPD6mat had IUGR, the phenotype appears to include IUGR as well as the potential to unmask an autosomal recessive trait.
Asunto(s)
Hiperplasia Suprarrenal Congénita/genética , Aneuploidia , Cromosomas Humanos Par 6 , Retardo del Crecimiento Fetal/genética , Intercambio Materno-Fetal/fisiología , Preescolar , Análisis Mutacional de ADN , Exones , Femenino , Genes Recesivos , Homocigoto , Humanos , Linaje , EmbarazoAsunto(s)
Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastorno Bipolar/diagnóstico , Edad de Inicio , Trastorno Bipolar/epidemiología , Niño , Comorbilidad , Diagnóstico Diferencial , Humanos , Entrevista Psicológica/normas , Padres , Escalas de Valoración Psiquiátrica/normas , Reproducibilidad de los ResultadosRESUMEN
Every child with a hearing loss should have an evaluation to determine the cause of hearing loss. This article focuses on the nongenetic origins of hearing loss, the most frequent of which is the neonatal intensive care unit experience, followed by meningitis, cytomegalovirus, and other infections. Preventable causes such as exposure to ototoxic medications and noise are also discussed in this article.
Asunto(s)
Trastornos de la Audición/etiología , Niño , Traumatismos Craneocerebrales/complicaciones , Trastornos de la Audición/inducido químicamente , Trastornos de la Audición/microbiología , Humanos , Infecciones/complicaciones , Unidades de Cuidado Intensivo Neonatal , Ruido/efectos adversosRESUMEN
PURPOSE: To determine the natural history of treated and untreated congenital toxoplasmosis and impact of this infection on vision. METHODS: In this prospective, longitudinal study, 76 newborns were treated with pyrimethamine and sulfadiazine for approximately one year, and 18 individuals not treated during their first year of life entered the study after age 1 year (historical patients). RESULTS: Chorioretinal scars were the most common eye finding in all patients and were most common in the periphery (58% of treated and 82% of historical patients). Macular scars were present in 54% of the treated patients; 41% were bilateral. Macular scars were present in 76% of the historical patients; 23% were bilateral. Visual acuity in the presence of macular lesions ranged from 20/20 to 20/400. Of the patients followed up from the newborn period and treated, 29% had bilateral visual impairment, with visual acuity for the best eye of less than 20/40. Causes for this visual impairment in eyes with quiescent lesions included macular scars, dragging of the macula secondary to a peripheral lesion, retinal detachment, optic atrophy, cataract, amblyopia, and phthisis. There were recurrences in both treated (13%, 7/54) and previously untreated historical patients (44%, 8/18). The total, median, and range of years of follow-up during which recurrences were observed were, for treated patients, 189 years (total), five years (median) and three to ten years (range) and, for historical, untreated patients, 160 years (total), 11 years (median), and three to 24 years (range). New lesions occurred in previously normal retinas and also contiguous to older scars. Active lesions appeared to become quiescent within ten to 14 days after beginning pyrimethamine and sulfadiazine therapy. CONCLUSION: Many children with congenital toxoplasmosis have substantial retinal damage at birth and consequent loss of vision. Nonetheless, vision may be remarkably good in the presence of large macular scars. Active lesions become quiescent with treatment.
Asunto(s)
Toxoplasmosis Congénita/complicaciones , Toxoplasmosis Ocular/complicaciones , Adolescente , Adulto , Antiinfecciosos/uso terapéutico , Niño , Preescolar , Enfermedades de la Coroides/etiología , Cicatriz/etiología , Femenino , Humanos , Lactante , Estudios Longitudinales , Masculino , Estudios Prospectivos , Pirimetamina/uso terapéutico , Enfermedades de la Retina/etiología , Sulfadiazina/uso terapéutico , Toxoplasmosis Congénita/fisiopatología , Toxoplasmosis Ocular/fisiopatología , Trastornos de la Visión/etiologíaRESUMEN
OBJECTIVE: The aim of this study was to measure nutrient intake and body composition in prepubescent children with Down syndrome to understand dietary barriers involved in the prevention and treatment of obesity. DESIGN: Dietary intake was determined from parent-reported 3-day diet records for children with Down syndrome and control subjects. Energy intake was compared with energy expenditure measured by the doubly labeled water method. Body composition was determined by deuterium dilution, bioelectrical impedance analysis, and skinfold thickness measurements. SUBJECTS/SETTING: Ten prepubescent children with Down syndrome and 10 control subjects were recruited from the hospital community. The study was conducted in the Clinical Research Center of the University of Chicago Medical Center. MAIN OUTCOME MEASURES: Nutrient intakes were compared with the Recommended Dietary Allowances (RDAs) to estimate risk for nutrient deficiency. Fat-free mass values determined by bioelectrical impedance analysis and measurement of skinfold thicknesses were compared with values determined using the deuterium dilution method. STATISTICAL ANALYSES PERFORMED: Unpaired t tests were used for comparisons between subjects groups and the Wilcoxon signed-rank test was used for comparison of nutrient intakes with RDAs. RESULTS: The subjects with Down syndrome were significantly shorter (P < .01) than control subjects; however, body composition did not differ between the groups. Reported energy intake was lower in subjects with Down syndrome. In addition, several micronutrients were consumed, especially among nonobese subjects with Down syndrome, at less than 80% of the RDA. APPLICATIONS: To avoid lowering already inadequate intakes of several vitamins and minerals, we suggest that treatment of obesity in children with Down syndrome combine a balanced diet without energy restriction, vitamin and mineral supplementation, and increased physical activity.
Asunto(s)
Dieta/normas , Síndrome de Down/metabolismo , Obesidad/prevención & control , Composición Corporal , Estatura , Niño , Preescolar , Registros de Dieta , Síndrome de Down/complicaciones , Síndrome de Down/tratamiento farmacológico , Metabolismo Energético , Femenino , Humanos , Masculino , Política Nutricional , Obesidad/etiologíaRESUMEN
After multidisciplinary medical diagnostic teams evaluate children with developmental delays, they recommend to parents that they seek specific services, but the team rarely knows which services are obtained. We sought to determine which services pursued by the parents were actually acquired and to determine if there were barriers to the acquisition of services. In a diagnostic clinic located in a teaching hospital in an urban setting, we evaluated 92 children less than 3 years of age mainly from an inner city population. At a family conference, the parents had indicated an interest in pursuing an average of 1.87 +/- 1.34 social services, 1.70 +/- 1.32 educational services, and 3.61 +/- 2.31 medical services recommended by the team. Four months after the family conference, the actual services obtained by families included 38.5% of the social services, 70.87% of the educational services, and 71.36% of the medical services. Significantly fewer social services were obtained than educational and medical services.
Asunto(s)
Discapacidades del Desarrollo/rehabilitación , Grupo de Atención al Paciente , Población Urbana , Chicago , Niño , Preescolar , Discapacidades del Desarrollo/diagnóstico , Discapacidades del Desarrollo/psicología , Intervención Educativa Precoz , Educación Especial , Femenino , Accesibilidad a los Servicios de Salud , Humanos , Masculino , Derivación y Consulta , Servicio SocialRESUMEN
Congenital transmission of Toxoplasma gondii from a mother who was apparently immunologically competent and who had toxoplasmic lymphadenitis 2 months before conception is described. Since no T. gondii-specific serological data were available for this mother from the time her lymph node biopsy specimen was obtained, the specimen was studied by polymerase chain reaction (PCR) to determine whether the T. gondii B1 gene was present. The predictive diagnostic value of histologic findings previously considered to be classic signs of T. gondii lymphadenitis also was studied. This was done by correlation of serological tests diagnostic of acute acquired T. gondii infection and presence of characteristic findings in biopsy specimens from persons without known immunocompromise. Both PCR and review of the characteristic features of her lymph node biopsy specimen confirmed the diagnosis of preconceptual infection in the mother. We also discuss two other cases in which apparently immunologically competent mothers with preconceptually acquired infection transmitted this parasite to their fetuses.
Asunto(s)
Fertilización , Transmisión Vertical de Enfermedad Infecciosa , Linfadenitis/parasitología , Toxoplasma/aislamiento & purificación , Toxoplasmosis/transmisión , Animales , Femenino , Humanos , Inmunocompetencia , Recién Nacido , Enfermedades del Recién Nacido , Ganglios Linfáticos/parasitología , Ganglios Linfáticos/patología , Linfadenitis/patología , Linfadenitis/fisiopatología , Ratones , Madres , Estudios Retrospectivos , Tomógrafos Computarizados por Rayos X , Toxoplasma/genética , Toxoplasmosis/parasitología , Toxoplasmosis/patología , Toxoplasmosis/fisiopatologíaRESUMEN
OBJECTIVE: To evaluate the short-term efficacy and side effects associated with two methylphenidate hydrochloride (MPH) dosing patterns. METHODS: Twenty-five boys with attention deficit hyperactivity disorder (ADHD) participated in a 5-week, triple-blind, placebo-controlled, crossover evaluation of MPH administered twice (b.i.d.) versus thrice (t.i.d.) per day (mean dose = 8.8 +/- 5 mg, .30 +/- .1 mg/kg/dose). Four dosing conditions (placebo, titration [gradual increase to target dose], b.i.d., and t.i.d.) were used. Dependent measures obtained on a weekly basis included: parent and teacher ratings of child behavior, parent-child conflicts, parent report of stimulant side effects, child self-report of mood symptoms, a sleep log, laboratory measures of attention, and actigraphic recording of sleep activity. RESULTS: All dosing conditions resulted in significant effects on ADHD symptoms when compared with baseline. Relative to placebo, t.i.d. dosing was characterized by improvement on the greatest number of behavioral measures, and both b.i.d. and t.i.d. were generally more effective than titration. Direct comparisons of b.i.d. and t.i.d. dosing revealed that t.i.d. was associated with greater improvement on the Conners Parent Rating Scale Impulsivity/Hyperactivity factor, with a similar marginally significant effect for the ADD-H Teacher Rating Scale Hyperactivity factor. The analysis of clinically significant change favored a three-times-a-day dosing schedule over placebo on both parent and teacher ratings of impulsivity/hyperactivity and attention. Compared with placebo, appetite suppression was rated, on average, as more severe in the t.i.d. and titration conditions, but not in the b.i.d. condition. However, the number of subjects who exhibited any or severe appetite suppression did not differ significantly between the b.i.d. and t.i.d. schedules. Although there was no difference in sleep duration for children on b.i.d. and t.i.d. schedules, total sleep time appeared to decrease slightly on t.i.d. relative to placebo according to both parent ratings and actigraphic assessment. There were no significant differences between b.i.d. and t.i.d. on any other side effects or sleep variables. CONCLUSIONS: For many children with ADHD, t.i.d. dosing may be optimal. There are few differences in acute side effects between b.i.d. and t.i.d. MPH dosing. The dosing schedule should be selected according to the severity and time course of ADHD symptoms rather than in anticipation of dosing schedule-related side effects.
Asunto(s)
Estimulantes del Sistema Nervioso Central/administración & dosificación , Metilfenidato/administración & dosificación , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Trastorno por Déficit de Atención con Hiperactividad/psicología , Cápsulas , Estimulantes del Sistema Nervioso Central/efectos adversos , Niño , Conducta Infantil/efectos de los fármacos , Cognición/efectos de los fármacos , Estudios de Seguimiento , Humanos , Masculino , Metilfenidato/efectos adversos , Sueño/efectos de los fármacos , Factores de TiempoRESUMEN
PURPOSE: To determine the natural history of treated and untreated congenital toxoplasmosis and impact of this infection on vision. METHODS: In this prospective, longitudinal study, 76 newborns were treated with pyrimethamine and sulfadiazine for approximately one year, and 18 individuals not treated during their first year of life entered the study after age 1 year (historical patients). RESULTS: Chorioretinal scars were the most common eye finding in all patients and were most common in the periphery (58% of treated and 82% of historical patients). Macular scars were present in 54% of the treated patients; 41% were bilateral. Macular scars were present in 76% of the historical patients; 23% were bilateral. Visual acuity in the presence of macular lesions ranged from 20/20 to 20/400. Of the patients followed up from the newborn period and treated, 29% had bilateral visual impairment, with visual acuity for the best eye of less than 20/40. Causes for this visual impairment in eyes with quiescent lesions included macular scars, dragging of the macula secondary to a peripheral lesion, retinal detachment, optic atrophy, cataract, amblyopia, and phthisis. There were recurrences in both treated (13%, 7/54) and previously untreated historical patients (44%, 8/18). The total, median, and range of years of follow-up during which recurrences were observed were, for treated patients, 189 years (total), five years (median), and three to ten years (range) and, for historical, untreated patients, 160 years (total), 11 years (median), and three to 24 years (range). New lesions occurred in previously normal retinas and also contiguous to older scars. Active lesions appeared to become quiescent within ten to 14 days after beginning pyrimethamine and sulfadiazine therapy. CONCLUSION: Many children with congenital toxoplasmosis have substantial retinal damage at birth and consequent loss of vision. Nonetheless, vision may be remarkably good in the presence of large macular scars. Active lesions become quiescent with treatment.
Asunto(s)
Toxoplasmosis Congénita/etiología , Toxoplasmosis Ocular/etiología , Adolescente , Adulto , Antiinfecciosos/uso terapéutico , Niño , Preescolar , Quimioterapia Combinada , Femenino , Fondo de Ojo , Humanos , Lactante , Estudios Longitudinales , Mácula Lútea/patología , Masculino , Estudios Prospectivos , Pirimetamina/uso terapéutico , Recurrencia , Enfermedades de la Retina/etiología , Enfermedades de la Retina/patología , Índice de Severidad de la Enfermedad , Sulfadiazina/uso terapéutico , Toxoplasmosis Congénita/tratamiento farmacológico , Toxoplasmosis Congénita/patología , Toxoplasmosis Ocular/tratamiento farmacológico , Toxoplasmosis Ocular/patología , Trastornos de la Visión/etiología , Trastornos de la Visión/patología , Agudeza VisualRESUMEN
PURPOSE: To determine the natural history of intracranial calcifications in infants with treated congenital toxoplasmosis. MATERIALS AND METHODS: Between January 1982 and March 1994, cranial computed tomography was performed in 56 infants with treated congenital toxoplasmosis when they were newborns and approximately 1 year old. Locations and sizes of intracranial calcifications were noted. RESULTS: Forty newborns had intracranial calcifications. By 1 year of age, calcifications diminished or resolved in 30 (75%) and remained stable in 10 (25%) of these treated infants. Ten (33%) of the 30 infants whose calcifications diminished versus seven (70%) of the 10 infants with stable calcifications received less intensive antimicrobial treatment than the other treated infants. In contrast, a small number of infants who were untreated or treated 1 month or less had intracranial calcifications that increased or remained stable during their 1st year of life. CONCLUSION: Diminution or resolution of intracranial calcifications was an unexpected and remarkable finding in infants with treated, congenital toxoplasmosis, consonant with their improved neurologic functioning.
Asunto(s)
Encéfalo/diagnóstico por imagen , Calcinosis/diagnóstico por imagen , Toxoplasmosis Cerebral/diagnóstico por imagen , Toxoplasmosis Congénita/diagnóstico por imagen , Antiinfecciosos/uso terapéutico , Calcinosis/etiología , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Leucovorina/uso terapéutico , Pirimetamina/uso terapéutico , Sulfadiazina/uso terapéutico , Factores de Tiempo , Tomografía Computarizada por Rayos X , Toxoplasmosis Cerebral/complicaciones , Toxoplasmosis Cerebral/tratamiento farmacológico , Toxoplasmosis Congénita/complicaciones , Toxoplasmosis Congénita/tratamiento farmacológicoRESUMEN
OBJECTIVE: To evaluate whether a pediatric family history obtained via a brief parent interview would reveal a high prevalence of psychiatric and developmental disorders in the family members of children with attention-deficit hyperactivity disorder (ADHD) compared with a group of children with another chronic developmental disability, Down syndrome (DS). DESIGN: A controlled cross-sectional group comparison study. SETTING: An interdisciplinary hyperactivity and learning problem clinic and a DS clinic located in a large, urban tertiary care teaching hospital in Chicago, Ill. PARTICIPANTS: A total of 140 children with ADHD and 163 children with DS of comparable socioeconomic status. MEASURES: Using a screening questionnaire and parent interview, the development pediatricians obtained a family history. RESULTS: By parent report, children with ADHD were significantly more likely than the control children with DS to have a parent affected by alcoholism (P = .007), other drug abuse (P < .001), depression (P < .001), delinquency (P < .001), learning disabilities (P < .001), and ADHD (P < .001). Similar patterns were evidenced in other first- and second-degree relatives. CONCLUSIONS: The high reported frequency of psychiatric and developmental disorders in the families of children with ADHD requires that the treating clinician explore the area of family psychiatric and developmental history and use the findings to formulate a comprehensive treatment plan that includes anticipatory guidance and psychosocial intervention.
Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/genética , Trastorno por Déficit de Atención con Hiperactividad/psicología , Discapacidades del Desarrollo/complicaciones , Trastornos Mentales/complicaciones , Padres , Adolescente , Niño , Preescolar , Estudios Transversales , Humanos , Encuestas y CuestionariosRESUMEN
Adaptive functioning was examined in children with Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD), and a psychiatric comparison group of children with pervasive developmental disorders or mild mental retardation (PDD/MR). As assessed with the Vineland Adaptive Behavior Scales, adaptive functioning was well below average for all three clinic groups. (The PDD/MR group had the lowest adaptive functioning scores, although not statistically different from the other groups). However, the level of adaptive functioning relative to IQ in the areas of Socialization, Communication and Daily Living was significantly lower for the ADD and ADHD groups. These deficits in adaptive functioning that characterize children with ADHD and ADD may help explain the poor long-term prognosis of ADHD, suggesting that increased attention should be paid to the assessment and treatment of adaptive functioning in individuals with ADHD and ADD.